Table of contents

  • Brand Names
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Caution and personalized dose adjustment in patients with the following genotypes
  • Drug Interactions
  • Nutrition/Nutraceutical Interactions
  • Dosage
  • Pharmacokinetics and Pharmacodynamics
  • Special Considerations

Brand Names

North America

USA: Sucraid.

Drug combinations


Sacrosidase: Mw: approx. 140000.01. β-Fructofuranosidase (Saccharomyces cerevisiae clone FI4 protein moiety reduced). CAS-85897-35-4 (1997).

Pharmacologic Category

Enzymes. (ATC-Code: A16AB06).

Mechanism of action

A naturally-occurring GI enzyme which breaks down disaccharide sucrose to its monosaccharide components (glucose and fructose).

Therapeutic use

Sucrase deficiency (congenital sucrase-isomaltase deficiency).

Pregnancy and lactiation implications

Animal studies not conducted. Should be administered to a pregnant woman only when indicated. Enters breast milk (compatible with lactation).

Unlabeled use


Hypersensitivity to yeast, yeast products, or glycerin.

Warnings and precautions

Hypersensitivity reactions to sacrosidase, including bronchospasm, reported. Product may contain papain (risk of severe hypersensitivity reactions).



Legal Notice
Privacy Policy
Cookie Policy


Phone: +34-981-780505
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart